<i>In vivo</i> CRISPR/Cas9-mediated gene integration corrects mucopolysaccharidosis type II in mice.

ABSTRACT:

SUBMITTER: Yu H 

PROVIDER: S-EPMC12828814 | biostudies-literature | 2026 May

REPOSITORIES: biostudies-literature